Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
10/2011
10/13/2011US20110251190 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
10/13/2011US20110251186 Amino-Oxazines and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use
10/13/2011US20110251178 Bicyclic Pyridinylpyrazoles
10/13/2011US20110251177 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/13/2011US20110251173 Chemical compounds
10/13/2011US20110250172 Hepatitis c virus inhibitors
10/13/2011CA2795523A1 Bicyclic pyrimidinyl pyrazoles
10/12/2011EP2374795A1 Sulphonic acid derivatives of polycyclic dyes used for analytical applications
10/12/2011CN1914177B Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/12/2011CN1849318B Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/12/2011CN102216308A [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
10/11/2011US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011US8034928 Fluorescence assays with improved sensitivity
10/11/2011US8034926 Methods of manufacturing crystalline forms of rapamycin analogs
10/11/2011US8034806 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
10/11/2011US8034804 (Pyrido/thieno)-[f]-oxazepine-5-one derivatives
10/11/2011CA2494235C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
10/11/2011CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
10/11/2011CA2247275C Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/06/2011WO2011123524A2 Macrolide inhibitors of mtor
10/06/2011WO2011121350A1 4 -amino -7,8- dihydropyrimido [5, 4 - f] [1, 4] oxazepin- 5 ( 6h) - one based dgat1 inhibitors
10/06/2011WO2011121105A1 Macrocyclic integrase inhibitors
10/06/2011US20110245259 5-Amino-2-(1-Hydroxy-Ethyl)-Tetrahydropyran Derivatives
10/06/2011US20110245254 Heterocyclic compounds as inhibitors of beta-lactamases
10/06/2011US20110245241 HIV Integrase Inhibitors
10/06/2011US20110245224 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
10/06/2011US20110243884 Biodegradable polymer - bioactive moiety conjugates
10/05/2011EP2370444A1 [4- (1-amino-ethyl) -cyclohexyl]-methyl-amines as antibacterials
10/05/2011EP2370437A1 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
10/05/2011EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011EP2370071A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
10/05/2011EP2144506B1 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
10/05/2011CN102209721A Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
10/05/2011CN102206217A Heterocyclic compounds for treating or preventing diabetes mellitus as dipeptidyl peptidase inhibitor
10/04/2011US8030458 Monoclonal antibodies to tacrolimus and immunoassays methods for tacrolimus
10/04/2011US8030325 Biosynthetic gene cluster for the production of a complex polyketide
09/2011
09/29/2011US20110237621 Macrocyclic Inhibitors of Hepatitis C Virus
09/29/2011US20110237577 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases
09/29/2011US20110237571 Phthalazine derivatives
09/29/2011US20110237569 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
09/29/2011CA2793949A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use
09/28/2011CN1915981B 2-oxy-benzoxazinone derivatives for the treatment of obesity
09/28/2011CN102203062A Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
09/28/2011CN102199116A Fluoro imido sugar compounds, and preparation method and application thereof
09/27/2011CA2503646C Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
09/22/2011WO2011115938A1 Spiro-tetracyclic ring compounds as beta - secretase modulators
09/22/2011WO2011115928A1 Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use
09/22/2011WO2011113111A1 Ionic liquids for batteries
09/22/2011WO2011049908A3 Bismacrokyclic compounds as hepatitis c virus inhibitors
09/22/2011WO2009111653A3 Antiviral therapeutic agents
09/22/2011US20110230531 Therapeutic compounds
09/22/2011US20110230497 Biologically active amides
09/22/2011US20110230477 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
09/22/2011US20110230468 Fused heterocyclic compounds and uses thereof
09/22/2011US20110230464 Purine derivatives useful as p13 kinase inhibitors
09/22/2011US20110230454 (aza)indole derivative and use thereof for medical purposes
09/22/2011CA2793125A1 New enzyme inhibitor compounds
09/22/2011CA2791389A1 Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use
09/22/2011CA2791281A1 Spiro-tetracyclic ring compounds as beta-secretase modulators
09/21/2011EP2366704A1 Inhibitors of serine proteases
09/21/2011EP2365976A1 Gamma secretase modulators
09/21/2011EP2365973A1 Gamma secretase modulators
09/21/2011EP2365970A1 Pyridazinones and their use as btk inhibitors
09/21/2011EP1505963B9 Hepatitis c virus inhibitors
09/21/2011CN102190661A Tricyclic benzopyran compound as anti-arrhythmic agents
09/21/2011CN102190621A N-heterocyclyl-phenylsubstituierte cyclische ketoenole
09/20/2011US8022207 Compound having affinity to amyloid
09/20/2011US8022085 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof
09/20/2011US8022084 Polymorphic forms of a GABAA agonist
09/20/2011US8022065 Purine derivatives as kinase inhibitors
09/20/2011US8022057 MAPK/ERK kinase inhibitors
09/15/2011WO2011112769A1 Compounds for the treatment of hepatitis c
09/15/2011WO2011112731A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011WO2011111817A1 Benzazepine compound
09/15/2011US20110224431 Triazolium Carbene Catalysts and Stereoselective Bond Forming Reactions Thereof
09/15/2011US20110224211 Anti-Viral Compounds, Compositions, And Methods Of Use
09/15/2011US20110224201 Cgrp receptor antagonists
09/15/2011US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
09/15/2011US20110224194 Staurosporine Derivatives as Inhibitors of FLT3 Receptor Tyrosine Kinase Activity
09/15/2011US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods
09/15/2011US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents
09/15/2011US20110223131 Antiviral compounds
09/15/2011CA2792918A1 Benzazepine compound
09/14/2011EP2364984A1 Inhibitors of serine proteases
09/14/2011EP2079472B1 High-purity large-scale preparation of stannsoporfin
09/14/2011EP1893620B1 Substituted spiro compounds and their use for producing pain-relief drugs
09/14/2011EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/14/2011CN1918172B Rifamycin analogs and uses thereof
09/14/2011CN1802187B Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
09/14/2011CN102186853A Alpha helix mimetics in the treatment of cancer
09/14/2011CN101360751B Oxygen linked pyrimidine derivatives
09/13/2011US8017641 P38 inhibitors and methods of use thereof
09/13/2011US8017619 Compositions useful as inhibitors of protein kinases
09/13/2011US8017604 Imidazopyridines
09/13/2011US8017603 Pyrimido [4,5-B]-oxazines for use as DGAT inhibitors
09/13/2011CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
09/13/2011CA2441565C Bisarylamines as potassium channel openers
09/09/2011WO2011107585A1 Morpholino substituted urea derivatives as mtor inhibitors
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/09/2011WO2011009075A3 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 220